226 related articles for article (PubMed ID: 27695914)
1. Brain natriuretic peptide for prevention of contrast-inducednephropathy: a meta-analysis of randomized controlled trials.
Wei XB; Jiang L; Liu XR; Yu DQ; Tan N; Chen JY; Zhou YL; He PC; Liu YH
Eur J Clin Pharmacol; 2016 Nov; 72(11):1311-1318. PubMed ID: 27695914
[TBL] [Abstract][Full Text] [Related]
2. Comparative efficacy of pharmacological interventions for contrast-induced nephropathy prevention after coronary angiography: a network meta-analysis from randomized trials.
Ma WQ; Zhao Y; Wang Y; Han XQ; Zhu Y; Liu NF
Int Urol Nephrol; 2018 Jun; 50(6):1085-1095. PubMed ID: 29404930
[TBL] [Abstract][Full Text] [Related]
3. Statins for the Prevention of Contrast-Induced Nephropathy After Coronary Angiography/Percutaneous Interventions: A Meta-analysis of Randomized Controlled Trials.
Liu YH; Liu Y; Duan CY; Tan N; Chen JY; Zhou YL; Li LW; He PC
J Cardiovasc Pharmacol Ther; 2015 Mar; 20(2):181-92. PubMed ID: 25193735
[TBL] [Abstract][Full Text] [Related]
4. The efficacy of N-acetylcysteine plus sodium bicarbonate in the prevention of contrast-induced nephropathy after cardiac catheterization and percutaneous coronary intervention: A meta-analysis of randomized controlled trials.
Zhao SJ; Zhong ZS; Qi GX; Tian W
Int J Cardiol; 2016 Oct; 221():251-9. PubMed ID: 27404685
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of short-term moderate or high-dose rosuvastatin in preventing contrast-induced nephropathy: A meta-analysis of 15 randomized controlled trials.
Liang M; Yang S; Fu N
Medicine (Baltimore); 2017 Jul; 96(27):e7384. PubMed ID: 28682890
[TBL] [Abstract][Full Text] [Related]
6. Remote Ischemic Conditioning for Preventing Contrast-Induced Acute Kidney Injury in Patients Undergoing Percutaneous Coronary Interventions/Coronary Angiography: A Meta-Analysis of Randomized Controlled Trials.
Bei WJ; Duan CY; Chen JY; Wang K; Liu YH; Liu Y; Tan N
J Cardiovasc Pharmacol Ther; 2016 Jan; 21(1):53-63. PubMed ID: 26112028
[TBL] [Abstract][Full Text] [Related]
7. Recombinant Brain Natriuretic Peptide for the Prevention of Contrast-Induced Nephropathy in Patients with Chronic Kidney Disease Undergoing Nonemergent Percutaneous Coronary Intervention or Coronary Angiography: A Randomized Controlled Trial.
Liu J; Xie Y; He F; Gao Z; Hao Y; Zu X; Chang L; Li Y
Biomed Res Int; 2016; 2016():5985327. PubMed ID: 26949703
[TBL] [Abstract][Full Text] [Related]
8. Brain natriuretic peptide for prevention of contrast-induced nephropathy after percutaneous coronary intervention or coronary angiography.
Liu JM; Xie YN; Gao ZH; Zu XG; Li YJ; Hao YM; Chang L
Can J Cardiol; 2014 Dec; 30(12):1607-12. PubMed ID: 25418218
[TBL] [Abstract][Full Text] [Related]
9. Meta-analysis of short-term high versus low doses of atorvastatin preventing contrast-induced acute kidney injury in patients undergoing coronary angiography/percutaneous coronary intervention.
Wu H; Li D; Fang M; Han H; Wang H
J Clin Pharmacol; 2015 Feb; 55(2):123-31. PubMed ID: 25310898
[TBL] [Abstract][Full Text] [Related]
10. Brain natriuretic peptide as a biomarker for predicting contrast-induced nephropathy in patients undergoing coronary angiography/intervention: A systematic review and meta-analysis.
Wu X; Yang X; Xu Z; Li J
Medicine (Baltimore); 2022 Dec; 101(52):e32432. PubMed ID: 36595981
[TBL] [Abstract][Full Text] [Related]
11. Evaluating biomarkers for contrast-induced nephropathy following coronary interventions: an umbrella review on meta-analyses.
Mahapatro A; Nobakht S; Mukesh S; Daryagasht AA; Korsapati AR; Jain SM; Soltani Moghadam S; Moosavi R; Javid M; Hassanipour S; Prabhu SV; Keivanlou MH; Amini-Salehi E; Nayak SS
Eur J Med Res; 2024 Apr; 29(1):210. PubMed ID: 38561791
[TBL] [Abstract][Full Text] [Related]
12. Remote ischemic preconditioning reduces the incidence of contrast-induced nephropathy in patients undergoing coronary angiography/intervention: Systematic review and meta-analysis of randomized controlled trials.
Pranata R; Tondas AE; Vania R; Toruan MPL; Lukito AA; Siswanto BB
Catheter Cardiovasc Interv; 2020 Nov; 96(6):1200-1212. PubMed ID: 31912996
[TBL] [Abstract][Full Text] [Related]
13. Prevention of contrast-induced nephropathy in STEMI patients undergoing primary percutaneous coronary intervention: a systematic review.
Busch SV; Jensen SE; Rosenberg J; Gögenur I
J Interv Cardiol; 2013 Feb; 26(1):97-105. PubMed ID: 23240788
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of brain natriuretic peptide
Mei Z; Luo S; Chen P; Zhang Q; Zhou L; Zhu C; Zhu H; Jin L
PeerJ; 2022; 10():e12975. PubMed ID: 35228908
[TBL] [Abstract][Full Text] [Related]
15. B-type natriuretic peptide for prevention of contrast-induced nephropathy in patients with heart failure undergoing primary percutaneous coronary intervention.
Zhang J; Fu X; Jia X; Fan X; Gu X; Li S; Wu W; Fan W; Su J; Hao G; Jiang Y; Xue L
Acta Radiol; 2010 Jul; 51(6):641-8. PubMed ID: 20438292
[TBL] [Abstract][Full Text] [Related]
16. Association of N-terminal pro-B-type natriuretic peptide with contrast-induced nephropathy and long-term outcomes in patients with chronic kidney disease and relative preserved left ventricular function.
Liu YH; Liu Y; Zhou YL; Yu DQ; He PC; Xie NJ; Li HL; Wei-Guo ; Chen JY; Tan N
Medicine (Baltimore); 2015 Apr; 94(13):e358. PubMed ID: 25837748
[TBL] [Abstract][Full Text] [Related]
17. Meta-analysis of randomized controlled trials of preprocedural statin administration for reducing contrast-induced acute kidney injury in patients undergoing coronary catheterization.
Giacoppo D; Capodanno D; Capranzano P; Aruta P; Tamburino C
Am J Cardiol; 2014 Aug; 114(4):541-8. PubMed ID: 25001154
[TBL] [Abstract][Full Text] [Related]
18. The effect of N-acetylcysteine on the incidence of contrast-induced kidney injury: A systematic review and trial sequential analysis.
Wang N; Qian P; Kumar S; Yan TD; Phan K
Int J Cardiol; 2016 Apr; 209():319-27. PubMed ID: 26922293
[TBL] [Abstract][Full Text] [Related]
19. Preprocedural N-terminal pro-brain natriuretic peptide (NT-proBNP) is similar to the Mehran contrast-induced nephropathy (CIN) score in predicting CIN following elective coronary angiography.
Liu Y; He YT; Tan N; Chen JY; Liu YH; Yang DH; Huang SJ; Ye P; Li HL; Ran P; Duan CY; Chen SQ; Zhou YL; Chen PY
J Am Heart Assoc; 2015 Apr; 4(4):. PubMed ID: 25888371
[TBL] [Abstract][Full Text] [Related]
20. Prophylactic atorvastatin prior to intra-arterial administration of iodinated contrast media for prevention of contrast-induced acute kidney injury: A meta-analysis of randomized trial data
.
Sun YY; Liu LY; Sun T; Wu MY; Ma FZ
Clin Nephrol; 2019 Sep; 92(3):123-130. PubMed ID: 31347493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
